Premium
Efficacy of sertraline for bulimia nervosa
Author(s) -
Sloan Denise M.,
Mizes J. Scott,
Helbok Craig,
Muck Rebekah
Publication year - 2004
Publication title -
international journal of eating disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.785
H-Index - 138
eISSN - 1098-108X
pISSN - 0276-3478
DOI - 10.1002/eat.20018
Subject(s) - sertraline , bulimia nervosa , psychology , psychopathology , psychiatry , clinical psychology , major depressive disorder , eating disorders , antidepressant , cognition , anxiety
Objective The current study examined the efficacy of sertraline in the treatment of individuals diagnosed with bulimia nervosa. Method Eighteen women enrolled in an 8‐week open trial of sertaline. Eating disorder psychopathology and depressive symptoms were assessed at baseline and at the end of the trial using both semistructured interviews and self‐report questionnaires. Results Findings indicated significant reductions in eating disorder psychopathology, including the number of binges and purges per week, as well as significant reductions in depressive symptoms. In addition, participants did not experience significant weight gain or any other sertraline side effect assessed at the end of the trial compared with baseline. Discussion Findings from the current study indicate that sertraline is efficacious in the treatment of bulimia nervosa. A double‐blind controlled trial of sertraline is recommended for future research. © 2004 by Wiley Periodicals, Inc. Int J Eat Disord 36: 48–54, 2004.